These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31402024)

  • 21. Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network.
    Ghys PD; Zaba B; Prins M
    AIDS; 2007 Nov; 21 Suppl 6(Suppl 6):S1-4. PubMed ID: 18032932
    [No Abstract]   [Full Text] [Related]  

  • 22. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis control in South Africa--will HAART help?
    Lawn SD; Wood R
    S Afr Med J; 2006 Jun; 96(6):502-4. PubMed ID: 16841129
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulling South Africa back from the HIV/AIDS brink. Interview by Jon Cohen.
    Motsoaledi A
    Science; 2013 Feb; 339(6122):902-3. PubMed ID: 23430631
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa.
    Skogmar S; Shakely D; Lans M; Danell J; Andersson R; Tshandu N; Odén A; Roberts S; Francois Venter WD
    AIDS Care; 2006 Oct; 18(7):725-30. PubMed ID: 16971281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hungering for HAART.
    Montaner JS; Hogg RS
    Ann Intern Med; 2007 Apr; 146(8):609-10. PubMed ID: 17438321
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV treatment in South Africa: overcoming impediments to get started.
    Abdool Karim Q
    Lancet; 2004 Apr; 363(9418):1394. PubMed ID: 15112695
    [No Abstract]   [Full Text] [Related]  

  • 30. Inspiring rural health--a fierce and distant light.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):576-7. PubMed ID: 16909173
    [No Abstract]   [Full Text] [Related]  

  • 31. Mantombazana Tshabalala-Msimang: South Africa's controversial health minister.
    Kapp C
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1131. PubMed ID: 15794958
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges to pediatric HIV care and treatment in South Africa.
    Meyers T; Moultrie H; Naidoo K; Cotton M; Eley B; Sherman G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S474-81. PubMed ID: 18181697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.
    Bobat R; Kindra G; Kiepiela P; Reddy S; Jeena PM; Adhikari M; Coovadia HM
    Pediatr Infect Dis J; 2010 Sep; 29(9):890. PubMed ID: 20720476
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of HIV infection on maternal health and mortality.
    Moran NF; Moodley J
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S26-9. PubMed ID: 22889550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengthening the health system and ensuring equity in the widescale implementation of an antiretroviral therapy programme in South Africa.
    Schneider H; Coetzee D
    S Afr Med J; 2003 Oct; 93(10):772-3. PubMed ID: 14652966
    [No Abstract]   [Full Text] [Related]  

  • 36. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applause for HIV/AIDS plan.
    van Niekerk JP
    S Afr Med J; 2007 May; 97(5):305. PubMed ID: 17599200
    [No Abstract]   [Full Text] [Related]  

  • 38. South Africa steps up.
    Lancet; 2009 Sep; 374(9692):757. PubMed ID: 19733766
    [No Abstract]   [Full Text] [Related]  

  • 39. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
    Liu C; Lerch V; Weber K; Schneider MF; Sharp GB; Gorapaju L; Sharma A; Levine A; Gandhi M; Merenstein D
    J Altern Complement Med; 2007 Dec; 13(10):1053-6. PubMed ID: 18166114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.